open access

Vol 6, No 3 (2005): Practical Diabetology
Original articles (submitted)
Published online: 2005-05-16
Get Citation

Risk of diabetes mellitus after gestational diabetes - review. Part I. Risk of diabetes mellitus after gestational diabetes

Aneta Malinowska-Polubiec, Krzysztof Czajkowski
Diabetologia Praktyczna 2005;6(3):126-135.

open access

Vol 6, No 3 (2005): Practical Diabetology
Original articles (submitted)
Published online: 2005-05-16

Abstract

A diagnosis of gestational diabetes often predicts future glucose homeostasis complications. Women with GDM in one pregnancy are at risk for development of glucose metabolism disturbances in a subsequent gestation. GDM has also been associated with a likelihood of subsequent diabetes in the nonpregnant state, which risk depends on the time since delivery. Earlier gestational age at diagnosis of gestational diabetes, high fasting and 2 h glucose level on the pregnancy oral glucose tolerance test (OGTT), high fasting and postprandial glucose level during pregnancy, need for insulin therapy during pregnancy, presence of autoimune markers of beta-cells destruction, macrosomic fetus, abnormal outcome of 6 weeks postpartum OGTT and number of gestational diabetic pregnancies were found to be most predictive of subsequent abnormal glucose metabolism. Age, gravidity, presence of diabetes in first-degree relatives, increased prepregnancy body mass index, maternal overweight at followup, weight gain after the GDM pregnancy, ethnic group, dyslipidemia (mainly: increased triglicerides, total cholesterol, LDL-cholesterol and decreased HDL-cholesterol), high fat diet also are associated with glucose intolerance in future life.

Abstract

A diagnosis of gestational diabetes often predicts future glucose homeostasis complications. Women with GDM in one pregnancy are at risk for development of glucose metabolism disturbances in a subsequent gestation. GDM has also been associated with a likelihood of subsequent diabetes in the nonpregnant state, which risk depends on the time since delivery. Earlier gestational age at diagnosis of gestational diabetes, high fasting and 2 h glucose level on the pregnancy oral glucose tolerance test (OGTT), high fasting and postprandial glucose level during pregnancy, need for insulin therapy during pregnancy, presence of autoimune markers of beta-cells destruction, macrosomic fetus, abnormal outcome of 6 weeks postpartum OGTT and number of gestational diabetic pregnancies were found to be most predictive of subsequent abnormal glucose metabolism. Age, gravidity, presence of diabetes in first-degree relatives, increased prepregnancy body mass index, maternal overweight at followup, weight gain after the GDM pregnancy, ethnic group, dyslipidemia (mainly: increased triglicerides, total cholesterol, LDL-cholesterol and decreased HDL-cholesterol), high fat diet also are associated with glucose intolerance in future life.
Get Citation

Keywords

gestational diabetes mellitus; risk of diabetes

About this article
Title

Risk of diabetes mellitus after gestational diabetes - review. Part I. Risk of diabetes mellitus after gestational diabetes

Journal

Clinical Diabetology

Issue

Vol 6, No 3 (2005): Practical Diabetology

Pages

126-135

Published online

2005-05-16

Bibliographic record

Diabetologia Praktyczna 2005;6(3):126-135.

Keywords

gestational diabetes mellitus
risk of diabetes

Authors

Aneta Malinowska-Polubiec
Krzysztof Czajkowski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl